PHARMACEUTICAL COMPOSITION IN IVERMECTIN EMULGEL FOR VETERINARY USE AS A PROMOTER SYSTEM AND BIO-ADHESIVE IN ANTIPARASITIC TREATMENT, AND METHOD FOR THE PRODUCTION THEREOF

USPTO Patent Application US 2017/0232026 A1
Application Date: Aug. 17th, 2017

ABSTRACT

The invention relates to a pharmaceutical composition comprising: at least one antiparasitic active ingredient for providing the pharmacological therapeutic effect; an agent having bio-adhesive properties that helps to reduce the...
Application Number:
15/503,033
International Classification:
A61K 31/7048 (20060101); A61K 47/32 (20060101); A61K 47/26 (20060101); A61K 47/44 (20060101); A61K 47/18 (20060101); A61K 9/06 (20060101); A61K 47/10 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1. A pharmaceutical composition comprising: at least an antiparasitic active principle in charge of providing a pharmacological therapeutic effect; an agent with bioadhesive properties helping to reduce motility and reproduction of infesting parasites, increasing the period of time of the product on the skin of animals; an agent with permeation...

DESCRIPTION

FIELD OF INVENTION

Present invention is related to principles and techniques used in veterinary pharmaceutical industry for antiparasitic treatment in small and large species and more specifically, it relates to an ivermectin emulgel pharmaceutical composition for veterinary use as bioadhesive promoter system for percutaneous application, being a new alternative for antiparasitic treatment; the...
Back to Top